Funded Symptom Science Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Perez-Lougee, Giselle Katiria	Massachusetts General Hospital United States	Thriving Beyond Treatment: A Resilience-Based Approach to Improve Long-term Quality of Life in Post-treatment Lymphoma Survivorship	1R37CA303094-01	Marjorie Perloff, M.D.
Perez-Lougee, Giselle Katiria	Massachusetts General Hospital United States	Thriving Beyond Treatment: A Resilience-Based Approach to Improve Long-term Quality of Life in Post-treatment Lymphoma Survivorship	1R37CA303094-01	Marjorie Perloff, M.D.
Perez-Lougee, Giselle Katiria	Massachusetts General Hospital United States	Thriving Beyond Treatment: A Resilience-Based Approach to Improve Long-term Quality of Life in Post-treatment Lymphoma Survivorship	1R37CA303094-01	Marjorie Perloff, M.D.
Pfleger, Cathie M	Icahn School Of Medicine At Mount Sinai United States	A Drosophila model for Aromatase Inhibitor-induced Musculoskeletal Pain	1R21CA303409-01	Rachel Altshuler, Ph.D.
Pfleger, Cathie M	Icahn School Of Medicine At Mount Sinai United States	A Drosophila model for Aromatase Inhibitor-induced Musculoskeletal Pain	1R21CA303409-01	Rachel Altshuler, Ph.D.
Phillips, Nicholas S	St. Jude Children'S Research Hospital United States	Cardiopulmonary function and cerebral blood flow in Hodgkin Lymphoma survivors	5R21CA280230-02	Eileen Dimond, R.N., M.S.
Phillips, Nicholas S	St. Jude Children'S Research Hospital United States	Cardiopulmonary function and cerebral blood flow in Hodgkin Lymphoma survivors	5R21CA280230-02	Eileen Dimond, R.N., M.S.
Pistilli, Emidio Edward	West Virginia University United States	Targeting Muscle Fatigability During Cachexia	5R01AR079445-04	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Pistilli, Emidio Edward	West Virginia University United States	Targeting Muscle Fatigability During Cachexia	5R01AR079445-04	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Plas, Ellen Van Der	Arkansas Children'S Hospital Res Inst United States	Identifying markers of abnormal neurocognitive trajectories during chemotherapy treatment of childhood acute lymphoblastic leukemia	5R37CA266135-04	Asad Umar, D.V.M., Ph.D.
Plas, Ellen Van Der	Arkansas Children'S Hospital Res Inst United States	Identifying markers of abnormal neurocognitive trajectories during chemotherapy treatment of childhood acute lymphoblastic leukemia	5R37CA266135-04	Asad Umar, D.V.M., Ph.D.
Plas, Ellen Van Der	Arkansas Children'S Hospital Res Inst United States	Identifying markers of abnormal neurocognitive trajectories during chemotherapy treatment of childhood acute lymphoblastic leukemia	5R37CA266135-04	Asad Umar, D.V.M., Ph.D.
Prigerson, Holly Gwen	Weill Medical Coll Of Cornell Univ United States	Behavioral and Psychosocial Effects on Study Outcomes in End-Stage Cancer Treatment (BEST End-Stage Cancer Study)	5R35CA197730-11	Brennan Streck, Ph.D., RN, M.P.H.
Prigerson, Holly Gwen	Weill Medical Coll Of Cornell Univ United States	Behavioral and Psychosocial Effects on Study Outcomes in End-Stage Cancer Treatment (BEST End-Stage Cancer Study)	5R35CA197730-11	Brennan Streck, Ph.D., RN, M.P.H.
Pyter, Leah M	Ohio State University United States	Chemotherapy-induced circadian master clock disruptions and fatigue	5R01CA270372-04	Marjorie Perloff, M.D.